Hyundai Mobis Co. has come up with an in-house brainwave-based driver monitoring system that can reduce the risk of drowsy driving by up to one-third.
The system, dubbed M.Brain, is a wearable earpiece that continuously detects and analyzes drivers' brain activity.
The company has examined the actual effect of the technology through a pilot study on public buses in Gyeonggi Province over the past year in partnership with the Gyeonggi Research Institute.
According to the findings, drivers who used M.Brain saw their risk of careless driving during after-meal hours, when drowsy driving is most common, drop by up to 30 percent.
M.Brain helped minimize the danger of careless driving by roughly 20% on highways where drowsy driving can lead to multi-car accidents.
When sloppy driving was detected in real-time, the device helped drivers recover attention within 2.3 seconds by blasting an alarm over the speakers and vibrating the seat.
This is nearly three times faster than the 6.7 seconds it took non-M.Brain drivers to regain attention.


Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
France Keeps Top Health Alert as Officials Brace for Another Heatwave
Trump Administration Releases New UFO Files and Apollo Mission Records
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
Should I take zinc or eat oysters to ward off colds, boost my immune system or improve fertility?
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
CIA-Linked Investor Helped Quantum Systems Expand in US
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
Trump Signs Order to Cut Routine Childhood Vaccines
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Toyota Global Sales Fall as China Demand Slumps
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Mercer International Stock Surges 45% on C$20 Million Canada Funding 



